NanoEntek, Inc.

Informe acción KOSDAQ:A039860

Capitalización de mercado: ₩128.4b

NanoEntek Resultados de beneficios anteriores

Pasado controles de criterios 0/6

NanoEntek's earnings have been declining at an average annual rate of -33.2%, while the Life Sciences industry saw earnings growing at 31.2% annually. Revenues have been growing at an average rate of 1.9% per year.

Información clave

-33.2%

Tasa de crecimiento de los beneficios

-33.5%

Tasa de crecimiento del BPA

Crecimiento de la industria Life Sciences 53.7%
Tasa de crecimiento de los ingresos1.9%
Rentabilidad financiera-0.7%
Margen neto-1.7%
Última actualización de beneficios30 Jun 2024

Actualizaciones de resultados anteriores recientes

Does NanoEnTek's (KOSDAQ:039860) Statutory Profit Adequately Reflect Its Underlying Profit?

Nov 23
Does NanoEnTek's (KOSDAQ:039860) Statutory Profit Adequately Reflect Its Underlying Profit?

Recent updates

Revenues Not Telling The Story For NanoEntek, Inc. (KOSDAQ:039860) After Shares Rise 32%

Oct 10
Revenues Not Telling The Story For NanoEntek, Inc. (KOSDAQ:039860) After Shares Rise 32%

NanoEntek, Inc.'s (KOSDAQ:039860) Revenues Are Not Doing Enough For Some Investors

Aug 06
NanoEntek, Inc.'s (KOSDAQ:039860) Revenues Are Not Doing Enough For Some Investors

NanoEntek, Inc.'s (KOSDAQ:039860) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Mar 21
NanoEntek, Inc.'s (KOSDAQ:039860) 25% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Should Weakness in NanoenTek, Inc.'s (KOSDAQ:039860) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Mar 14
Should Weakness in NanoenTek, Inc.'s (KOSDAQ:039860) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

If You Had Bought NanoEnTek (KOSDAQ:039860) Shares A Year Ago You'd Have Earned 48% Returns

Jan 26
If You Had Bought NanoEnTek (KOSDAQ:039860) Shares A Year Ago You'd Have Earned 48% Returns

Calculating The Intrinsic Value Of NanoEnTek, Inc. (KOSDAQ:039860)

Jan 04
Calculating The Intrinsic Value Of NanoEnTek, Inc. (KOSDAQ:039860)

NanoEnTek Inc.'s (KOSDAQ:039860) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Dec 14
NanoEnTek Inc.'s (KOSDAQ:039860) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Does NanoEnTek's (KOSDAQ:039860) Statutory Profit Adequately Reflect Its Underlying Profit?

Nov 23
Does NanoEnTek's (KOSDAQ:039860) Statutory Profit Adequately Reflect Its Underlying Profit?

Desglose de ingresos y gastos

Cómo gana y gasta dinero NanoEntek. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

KOSDAQ:A039860 Ingresos, gastos y beneficios (KRW Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Jun 2427,804-4738,8583,689
31 Mar 2427,060-2,8369,5983,689
31 Dec 2326,837-3,6789,7943,689
30 Sep 2326,656-5,0439,8673,550
30 Jun 2329,016-1,19910,0383,550
31 Mar 2331,5742,5058,9273,550
31 Dec 2235,2014,6658,0683,550
30 Sep 2237,7117,5058,3872,968
30 Jun 2236,0355,9617,9142,968
31 Mar 2234,5026,0287,5522,968
31 Dec 2135,7847,3218,0212,968
30 Sep 2136,1076,9448,9792,455
30 Jun 2135,0766,2358,2442,455
31 Mar 2134,5134,4637,8712,455
31 Dec 2029,4432,7377,1472,455
30 Sep 2026,3193,8879,155386
30 Jun 2026,9875,5658,486825
31 Mar 2028,1027,1827,5371,182
31 Dec 1926,2565,7506,7441,519
30 Sep 1925,3884,4076,3721,452
30 Jun 1924,8953,5006,1511,276
31 Mar 1923,8512,8435,9371,222
31 Dec 1825,7973,3085,6741,241
30 Sep 1825,7547185,3371,340
30 Jun 1825,4741385,6281,463
31 Mar 1824,895-6585,8771,496
31 Dec 1723,810-2,0725,5651,376
30 Sep 1723,080-7,3857,7561,591
30 Jun 1722,454-9,6218,0151,712
31 Mar 1722,289-12,9579,4101,893
31 Dec 1622,206-14,79910,6282,111
30 Sep 1624,877-11,14610,7882,020
30 Jun 1624,730-10,67911,2141,734
31 Mar 1625,706-8,77710,1081,535
31 Dec 1524,839-7,28210,0191,332
30 Sep 1523,548-3,1457,902980
30 Jun 1522,069-2,7367,011942
31 Mar 1519,664-2,7456,633859
31 Dec 1419,499-2,4645,874740
30 Sep 1419,097-2,1175,291495
30 Jun 1419,529-1,7524,697388
31 Mar 1419,253-1,0354,471329
31 Dec 1319,084-1,2374,278438

Ingresos de calidad: A039860 is currently unprofitable.

Margen de beneficios creciente: A039860 is currently unprofitable.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: A039860 is unprofitable, and losses have increased over the past 5 years at a rate of 33.2% per year.

Acelerando crecimiento: Unable to compare A039860's earnings growth over the past year to its 5-year average as it is currently unprofitable

Beneficios vs. Industria: A039860 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (18%).


Rentabilidad financiera

Alta ROE: A039860 has a negative Return on Equity (-0.66%), as it is currently unprofitable.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado